Saturday , November 25 2017
Home / Letter From The Editor (page 3)

Letter From The Editor

Sept. 19, 2017

On most Saturday mornings I go out at 8 AM with our local bike club for a 30 to 40 mile ride. I usually wake up about 6 AM, and will turn on my local NPR station and tune into the People’s Pharmacy. Joe and Terry Graedon have been hosting the show …

Read More »

Sept. 16, 2017

There always seems to be a resistance to using newer drugs in combination. Prescribers have never had a problem using metformin in combination with almost any other diabetes medication. Often you will see metformin, basal insulin, and a new drug used, but there has not been a lot of mixing …

Read More »

Sept. 12, 2017

I am sitting on my front porch after cleaning up from Hurricane Irma. We do not yet have electricity, but thanks to modern technology I can text, talk, and send emails. As we were helping our neighbor put their fence back up, I got a call from an older patient …

Read More »

Sept. 9, 2017

This week we have a great feature from David Kliff on what is the newest and greatest for diabetes care, and what some of the problems will be. But I would rather look at a couple of old school products that we should be more aggressive with. The first is …

Read More »

Sept. 5, 2017

Last week I was at home and got a call from a physician who I used to see patients for. He was in his late 50s and the ever-increasing workload in his practice had put a damper on his physical activity; therefore, he had gained some weight. This, of course, …

Read More »

Sept. 2, 2017

About 5 months ago, we got a new couch and it is really comfortable. One end has a chaise lounge and it is great for watching Amazon Prime. I love to come in, make a nice cappuccino, and lie back and watch my current binge series “Covert Affairs.” Then suddenly …

Read More »

Aug. 29, 2017

If you put glycocalyx in Google search, you will find a definition that includes “a glycoprotein covering that surrounds the cell membranes of some bacteria, epithelia and other cells.” This does not make much sense when you’re trying to help prevent kidney disease, but this glycoprotein has a lot to do with …

Read More »

Aug. 26, 2017

It was not uncommon a few years ago to take a patient off metformin when they went on insulin. Metformin was considered a type 2 drug and when someone either had type 1 or they became insulin dependent there was no real value for metformin. I spent 13 years working …

Read More »

Aug. 22, 2017

Too often when we see patients we arbitrarily give them a goal A1c. Most of us don’t make every person strive for 5.7, but we sometimes forget to find out what the patient really thinks they can accomplish. This week we combined information from Dr. Karl Nadolsky and our Medical Editor to …

Read More »

Aug. 19, 2017

This week we have an interesting article on the use of nonnutritive sweeteners.  Over the years, we have had many of these as one opinion or another had flip-flopped as to the benefit or harm of these products. As an educator, I have always been in favor of using them …

Read More »